meta_pixel
Tapesearch Logo
Log in
Moonshots with Peter Diamandis

David Sinclair: The GLP-1 Side Effect No One Talks About, What AI Found in His Lab, and Reversing Blindness | Q&A EP #251

Moonshots with Peter Diamandis

PHD Ventures

Business

4.8 • 605 Ratings

🗓️ 28 April 2026

⏱️ 27 minutes

🧾️ Download transcript

Summary

This episode was filmed at the 2026 Abundance360 Summit. Learn more at https://www.abundance360.com/ This Q&A is about longevity, and especially how David Sinclair sees AI speeding up drug discovery, biological-age reversal, and the future of healthspan. It also covers GLP-1s, telomeres, genetics, muscle preservation, hormone replacement, indoor environment, and the role of mindset in aging well. Get access to metatrends 10+ years before anyone else - https://qr.diamandis.com/metatrends   Peter H. Diamandis, MD, is the Founder of XPRIZE, Singularity University, ZeroG, and A360 David A. Sinclair, A.O., Ph.D., is a tenured Professor of Genetics at Harvard Medical School and a serial biotech entrepreneur. Peter H. Diamandis, MD, is the Founder of XPRIZE, Singularity University, ZeroG, and A360 – My companies: Apply to Dave's and my new fund:https://qr.diamandis.com/linkventureslanding      Go to Blitzy to book a free demo and start building today: https://qr.diamandis.com/blitzy   Your body is incredibly good at hiding disease. Schedule a call with Fountain Life to add healthy decades to your life, and to learn more about their Memberships: https://www.fountainlife.com/peter  _ Connect with Peter: X Instagram Substack Website Xprize Connect with David  X Instagram Website Listen to MOONSHOTS: Apple YouTube – *Recorded on March 9th, 2026 *The views expressed by me and all guests are personal opinions and do not constitute Financial, Medical, or Legal advice. Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcript

Click on a timestamp to play from that location

0:00.0

There's a lot to say about GLP-1s.

0:02.0

More and more data is coming out showing benefits to the heart, the brain, beyond just weight loss.

0:06.0

There is one downside that I need to point out besides what's known about risks.

0:11.0

We are working with companies and academics that do a lot of AI now.

0:16.0

It's accelerating our work exponentially.

0:19.0

AI-driven drug design and looking at billions and eventually trillions of molecules

0:23.6

to see which ones might reverse aging.

0:26.6

We've done that already.

0:27.6

And if anyone tells you AI can only do what we've taught it,

0:30.6

that is the biggest bunch of BS you'll ever hear.

0:33.6

My ancestors die in their 70s.

0:34.6

My grandmother had a stroke in her 30s. So the fact that my father is now living in a healthy way beyond any of his ancestors probably ever

0:42.3

is testament that you can really change what your genes have given you.

0:46.3

One thing that is the most powerful, your mindset.

0:49.3

I think this is the most exciting time ever to be alive.

0:51.3

I want to see as much of it as I possibly can.

0:57.1

Now that's the moonshot, ladies and gentlemen.

1:02.0

A rare opportunity here. I think we have about 25 minutes for Q&A or so. And, you know, sleep

1:08.2

and exercise. I think you and I differentiate a little bit on that because I'm like, I like sleep for me trying to get eight hours and I'm trying to be in the gym five days a week.

1:21.0

You're not as, where do you stand on sleep and exercise?

1:24.7

I would be sleeping a lot more and exercising a lot more if I wasn't traveling on an

1:30.1

airplane most of the time and in the lab. But I have a standing desk and I have a treadmill at home

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from PHD Ventures, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of PHD Ventures and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.